Related references
Note: Only part of the references are listed.Prion protein/protein interactions:: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells
Carmen Krammer et al.
FASEB JOURNAL (2008)
Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases
Chantal Zuber et al.
MOLECULAR IMMUNOLOGY (2008)
Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures
Sabrina Cronier et al.
JOURNAL OF VIROLOGY (2007)
Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide
Rona Wilson et al.
BMC NEUROSCIENCE (2007)
Cyclic tetrapyrrole sulforlation, metals, and oligomerization in antiprion activity
Winslow S. Caughey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Aging and regulated protein degradation: who has the UPPer hand?
Vita A. Vernace et al.
AGING CELL (2007)
The CNS glycoprotein Shadoo has PrPC-like protective properties and displays reduced levels in prion infections
Joel C. Watts et al.
EMBO JOURNAL (2007)
Polylactide-coglycolide microspheres coencapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses
Gunnar Kaiser-Schulz et al.
JOURNAL OF IMMUNOLOGY (2007)
Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formation
Sabine Gilch et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery
Seong-Wook Yun et al.
JOURNAL OF NEUROVIROLOGY (2007)
In vitro and in vivo neurotoxicity of prion protein oligomers
Steve Simoneau et al.
PLOS PATHOGENS (2007)
Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate
A. Parry et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Antibodies to a nonconjugated prion protein peptide 95-123 interfere with PrPSc propagation in prion-infected cells
Maria B. Oboznaya et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2007)
Disease-associated prion protein oligomers inhibit the 26S proteasome
Mark Kristiansen et al.
MOLECULAR CELL (2007)
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
Joseph El Khoury et al.
NATURE MEDICINE (2007)
Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells
Alessandra Handisurya et al.
FEBS JOURNAL (2007)
Phosphorothioate oligonucleotides reduce PrPSc levels and prion infectivity in cultured cells
Marcela V. Karpuj et al.
MOLECULAR MEDICINE (2007)
Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases
Claire Larramendy-Gozalo et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Molecular basis of cerebral neurodegeneration in prion diseases
Joerg Tatzelt et al.
FEBS JOURNAL (2007)
Targeting cellular prion protein reverses early coanitive deficits and neurophysiological dysfunction in prion-infected mice
Giovanna R. Mallucci et al.
NEURON (2007)
Lethal recessive myelin toxicity of prion protein lacking its central domain
Frank Baumann et al.
EMBO JOURNAL (2007)
Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125
Aimin Li et al.
EMBO JOURNAL (2007)
Comparative genomic analysis of prion genes
Marko Premzl et al.
BMC GENOMICS (2007)
Packaging of prions into exosomes is associated with a novel pathway of PrP processing
L. J. Vella et al.
JOURNAL OF PATHOLOGY (2007)
The cellular prion protein (PrPC): Its physiological function and role in disease
Laura Westergard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report
Stephen J. Wroe et al.
LANCET (2006)
Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice
Alexander Pfeifer et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Prions and their partners in crime
Byron Caughey et al.
NATURE (2006)
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Michael T. Lin et al.
NATURE (2006)
DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge
Natalia Fernandez-Borges et al.
JOURNAL OF VIROLOGY (2006)
CNS immune privilege: hiding in plain sight
Monica J. Carson et al.
IMMUNOLOGICAL REVIEWS (2006)
Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP
Angelika S. Rambold et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Lentiviral transgenesis - A versatile tool for basic research and gene therapy
Alexander Pfeifer
CURRENT GENE THERAPY (2006)
Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease
IR Whittle et al.
ACTA NEUROCHIRURGICA (2006)
Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons
V Novitskaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity
XH Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Clearance and prevention of prion infection in cell culture by anti-PrP antibodies
Joanna Pankiewicz et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Suppression of prion protein in livestock by RNA interference
MC Golding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Amyloids, prions and the inherent infectious nature of misfolded protein aggregates
C Soto et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides
DA Kocisko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Prions in skeletal muscles of deer with chronic wasting disease
RC Angers et al.
SCIENCE (2006)
A porphyrin increases survival time of mice after intracerebral prion infection
DA Kocisko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The prion protein requires cholesterol for cell surface localization
S Gilch et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Creutzfeldt-Jakob disease and blood transfusion: Results of the UK transfusion medicine epidemiological review study
P. E. Hewitt et al.
VOX SANGUINIS (2006)
Fusion of Doppel to octapeptide repeat and N-terminal half of hydrophobic region of prion protein confers resistance to serum deprivation
DC Lee et al.
MICROBIOLOGY AND IMMUNOLOGY (2006)
Protein aggregation and its consequences for human disease
CM Dobson
PROTEIN AND PEPTIDE LETTERS (2006)
KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity
V Vetrugno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis
M Kristiansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Aggravation of ischemic brain injury by prion protein deficiency: Role of ERK-1/-2 and STAT-1
A Spudich et al.
NEUROBIOLOGY OF DISEASE (2005)
Mechanisms of disease - Sick chaperones, cellular stress, and disease
AJL Macario et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The most infectious prion protein particles
JR Silveira et al.
NATURE (2005)
Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies
G Donofrio et al.
JOURNAL OF VIROLOGY (2005)
Molecular neurology of prion disease
J Collinge
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Anchorless prion protein results in infectious amyloid disease without clinical scrapie
B Chesebro et al.
SCIENCE (2005)
Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease
NV Todd et al.
JOURNAL OF INFECTION (2005)
Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets
U Bertsch et al.
JOURNAL OF VIROLOGY (2005)
PrPSc incorporation to cells requires endogenous glycosaminoglycan expression
N Hijazi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heparan sulfate is a cellular receptor for purified infectious prions
L Horonchik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Semiautomated cell-free conversion of prion protein: Applications for high-throughput screening of potential antiprion drugs
L Breydo et al.
ANALYTICAL BIOCHEMISTRY (2005)
Circumventing tolerance to the prion protein (PrP): Vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP
D Nikles et al.
JOURNAL OF VIROLOGY (2005)
Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, protective glial stem cells and stromal ependymal cells
M Hauwel et al.
BRAIN RESEARCH REVIEWS (2005)
Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells
C Féraudet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations
L Fioriti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation
A Cardinale et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mucosal vaccination delays or prevents prion infection via an oral route
F Goni et al.
NEUROSCIENCE (2005)
Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models
K Doh-Ura et al.
JOURNAL OF VIROLOGY (2004)
Squalestatin cures prion-infected neurons and protects against prion neurotoxicity
C Bate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrP degradation
V Perrier et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Efficacy of flupirtine on cognitive function in patients with CJD - A double-blind study
M Otto et al.
NEUROLOGY (2004)
The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum
J Heske et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
CA Llewelyn et al.
LANCET (2004)
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration
M Heikenwalder et al.
NATURE MEDICINE (2004)
Mammalian prion biology: One century of evolving concepts
A Aguzzi et al.
CELL (2004)
The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells
A Ertmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
PrPSc binding antibodies are potent inhibitors of prion replication in cell lines
V Beringue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease
VH Perry
BRAIN BEHAVIOR AND IMMUNITY (2004)
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
AH Peden et al.
LANCET (2004)
Multiple antigenic peptides facilitate generation of anti-prion antibodies
J Bainbridge et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects
S Haïk et al.
NEUROLOGY (2004)
Combined quinacrine and chlorpromazine therapy in fatal familial insomnia
J Benito-León
CLINICAL NEUROPHARMACOLOGY (2004)
Prion protein accumulation and neuroprotection in hypoxic brain damage
NF McLennan et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity
J Weise et al.
NEUROSCIENCE LETTERS (2004)
Protection from cytosolic prion protein toxicity by modulation of protein translocation
NS Rane et al.
EMBO JOURNAL (2004)
Cationic phosphorus-contain ing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie
J Solassol et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Male infertility and DNA damage in Doppel knockout and prion protein/Doppel double-knockout mice
D Paisley et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection
M Polymenidou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The complement system in prion diseases
NA Mabbott
CURRENT OPINION IN IMMUNOLOGY (2004)
Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis
O Schonberger et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization
M Arbel et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Games played by rogue proteins in prion disorders and Alzheimer's disease
A Aguzzi et al.
SCIENCE (2003)
Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis
G Mallucci et al.
SCIENCE (2003)
Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent
A Schwarz et al.
NEUROSCIENCE LETTERS (2003)
New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products
DA Kocisko et al.
JOURNAL OF VIROLOGY (2003)
Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability - A critical role for the putative transmembrane domain
U Heller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Shadoo, a new protein highly conserved from fish to mammals and with similarity to prion protein
M Premzl et al.
GENE (2003)
Prophylactic and therapeutic effects of phthalocyanine tetrasulfonate in scrapie-infected mice
SA Priola et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Isolation of drugs active against mammalian prions using a yeast-based screening assay
S Bach et al.
NATURE BIOTECHNOLOGY (2003)
A novel generation of heparan sulfate mimetics for the treatment of prion diseases
KT Adjou et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Evaluation of quinacrine treatment for prion diseases
A Barret et al.
JOURNAL OF VIROLOGY (2003)
Specific inhibition of pathological prion protein accumulation by small interfering RNAs
N Daude et al.
JOURNAL OF CELL SCIENCE (2003)
Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia
E Flechsig et al.
EMBO JOURNAL (2003)
Efficient and specific down-regulation of prion protein expression by RNAi
G Tilly et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells
S Gilch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Analysis of doppel protein toxicity
T Cui et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines
BCH May et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Monoclonal antibodies inhibit prion replication and delay the development of prion disease
AR White et al.
NATURE (2003)
The 37 kDa/67 kDa laminin receptor is required for PrPSc propagation in scrapie-infected neuronal cells
C Leucht et al.
EMBO REPORTS (2003)
Other animal prion diseases
CJ Sigurdson et al.
BRITISH MEDICAL BULLETIN (2003)
Biochemistry and structure of PrPC and PrPSc
D Riesner
BRITISH MEDICAL BULLETIN (2003)
Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains
B Caughey
BRITISH MEDICAL BULLETIN (2003)
Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol
JY Ma et al.
SCIENCE (2002)
Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol
JY Ma et al.
SCIENCE (2002)
Induction of antibodies against murine full-length prion protein in wild-type mice
MF Koller et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Tetracyclines affect prion infectivity
G Forloni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Postexposure prophylaxis against prion disease with a stimulator of innate immunity
S Sethi et al.
LANCET (2002)
Absence of the prion protein homologue Doppel causes male sterility
A Behrens et al.
EMBO JOURNAL (2002)
Immunization delays the onset of prion disease in mice
EM Sigurdsson et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Cellular prion protein transduces neuroprotective signals
LB Chiarini et al.
EMBO JOURNAL (2002)
Atypical inflammation in the central nervous system in prion disease
VH Perry et al.
CURRENT OPINION IN NEUROLOGY (2002)
Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration
GR Mallucci et al.
EMBO JOURNAL (2002)
Doppel-induced cerebellar degeneration in transgenic mice
RC Moore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor
C Hundt et al.
EMBO JOURNAL (2001)
Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies
FL Heppner et al.
SCIENCE (2001)
Transepithelial prion transport by M cells
FL Heppner et al.
NATURE MEDICINE (2001)
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity
D Peretz et al.
NATURE (2001)
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
C Korth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Intracellular re-routing of prion protein prevents propagation of PrPSc and delays onset of prion disease
S Gilch et al.
EMBO JOURNAL (2001)
Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody
M Enari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay
JDF Wadsworth et al.
LANCET (2001)
Microglia and Prion disease
DR Brown
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain
M Horiuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Branched polyamines cure prion-infected neuroblastoma cells
S Supattapone et al.
JOURNAL OF VIROLOGY (2001)
Prions and the lymphoreticular system
C Weissmann et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Sulfated glycans and elevated temperature stimulate PrPSc-dependent cell-free formation of protease-resistant prion protein
C Wong et al.
EMBO JOURNAL (2001)
Prion diseases of humans and animals: Their causes and molecular basis
J Collinge
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Enhanced CD9 expression in the mouse and human brains infected with transmissible spongiform encephalopathies
K Doh-ura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Nucleated conformational conversion and the replication of conformational information by a prion determinant
TR Serio et al.
SCIENCE (2000)
Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice
E Flechsig et al.
NEURON (2000)
Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells
KF Winklhofer et al.
BIOLOGICAL CHEMISTRY (2000)
Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures
A Mangé et al.
JOURNAL OF VIROLOGY (2000)
Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation
K Doh-Ura et al.
JOURNAL OF VIROLOGY (2000)
Porphyrin and phthalocyanine antiscrapie compounds
SA Priola et al.
SCIENCE (2000)
Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides
C Soto et al.
LANCET (2000)
Share Paper
